Prosecution Insights
Last updated: July 17, 2026

McDermott Will & Emery, LLP

58 pending office actions • 34 clients • 54 examiners • 42 art units • 2 of 58 (3%) have an AI response strategy ready • 81 patents granted in the last 365 days

Quality Metrics (n=36798 apps, methodology: how we score firms)

86.4%
Allowance Rate
n=36798
+0.54σ
Allowance Rate (norm)
n=36798
3.3
OAs to Allowance
n=27091
-0.09σ
OAs to Allow (norm)
n=27091
1047 days
Time to Allowance
n=27091
+4.9pp
Interview Lift
n=36798
24.7%
RCE Rate
n=36798
1.6%
Appeal Rate
n=36798

Rejection Performance (% of received rejections ultimately overcome)

85.7%
§101 Overcome
n=523
88.1%
§102 Overcome
n=3832
87.1%
§103 Overcome
n=15086
93.2%
§112 Overcome
n=2307

Specialization & Scale

H01L, G06F, H10W
Top CPC Subclasses
12%
Top-3 CPC Share
n=36798
9
Practitioners
n=36798
4088.7
Apps / Practitioner
n=36798

Portfolio Summary

58
Total Pending OAs
36
Non-Final OAs
21
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 33 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

20
Overdue
1
Due this week
5
Due this month
7
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 33 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (20)Due ≤ 7 days (1)Due ≤ 30 days (5)Due ≤ 60 days (7)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (14%)
37
Medium (64%)
8
Easy (14%)
5
Unknown (9%)

Rejection Statute Mix

BucketCases
§101 only8 (14%)
§103 only35 (60%)
§102 only2 (3%)
§112 only6 (10%)
Double-patenting only2 (3%)
No statute on record5 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

24
Life Sciences
41% of docket
3
Information Tech
5% of docket
5
Communications
9% of docket
2
Semiconductors
3% of docket
17
Mechanical / Eng
29% of docket
7
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

580 h
Manual time on pending OAs
116 h
Time saved (low, 20%)
203 h
Time saved (mid, 35%)
5.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DETWEILER, JAMES M 2 38.9% +43.2%
PRONE, CHRISTOPHER D 2 64.9% +19.3%
LOCKARD, JON MCCLELLAND 2 74.7% +27.0%
AEDER, SEAN E 2 56.7% +20.0%
HALE, GLORIA M 1 73.0% +19.2%
DAGER, JONATHAN M 1 82.2% +4.7%
WORJLOH, JALATEE 1 64.2% +38.1%
ELLIS, SUEZU Y 1 76.6% +21.7%
JEAN GILLES, JUDE 1 92.8% +2.5%
GELAGAY, SHEWAYE 1 71.8% +45.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19234634 LANE CHANGE DETERMINATION FOR VEHICLE ON SHOULDER DAGER, JONATHAN M
19086306 DECLARATIVE DIGITAL TWINS JEAN GILLES, JUDE

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17997500 SYSTEM AND METHOD TO IDENTIFY SUITABLE PATIENT SUBGROUPS FOR BIOLOGICS KANAAN, LIZA TONY 81d overdue
17458174 SYSTEM AND APPARATUS FOR POINT-OF-CARE DIAGNOSTICS GERIDO, DWAN A 66d overdue
17781652 USE OF CELL FREE NUCLEOSOMES AS BIOMARKERS AEDER, SEAN E 25d overdue
18552094 SYSTEM TO SELECT IN-STORE OR E-COMMERCE CHANNELS FOR OPTIMIZED DELIVERY OF CREATIVE MEDIA TO CONSUMERS POUNCIL, DARNELL A 16d overdue
18256191 DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS AEDER, SEAN E 9d
17750787 NATURAL LANGUAGE ANALYSIS OF USER SENTIMENT BASED ON DATA OBTAINED DURING USER WORKFLOW ARMSTRONG, ANGELA A 14d
17895953 TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS DUNN, MCKENZIE A
17658798 SYSTEMS AND METHODS FOR ANALYZING USER INTERACTION DATA USING MACHINE LEARNING TO ORGANIZE SEARCH RESULTS CLARE, MARK C

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17781652 USE OF CELL FREE NUCLEOSOMES AS BIOMARKERS AEDER, SEAN E 25d overdue
19260921 UNDERGARMENT FOR WOMEN WITH SLEEVES HALE, GLORIA M 3d overdue
18256191 DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS AEDER, SEAN E 9d
19096095 TOOL IDENTIFIER RECOGNITION AND SENSOR CALIBRATION IN A TOOL CONTROL SYSTEM ELLIS, SUEZU Y 33d
18695464 TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF LOCKARD, JON MCCLELLAND 39d
18751839 THREE-DIMENSIONAL LATTICE STRUCTURES FOR IMPLANTS PRONE, CHRISTOPHER D 56d
19180648 ENCRYPTED SUBNETS AND SECURE CONTAINERS WORJLOH, JALATEE
19078927 SECURITY IN RADIO ACCESS NETWORKS GELAGAY, SHEWAYE

Client Portfolio (34 clients)

Top Art Units

Art UnitApps
36213
37742
26112
16472
36222
16822
16782
16422
37321
36971

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19260921 UNDERGARMENT FOR WOMEN WITH SLEEVES Ravden Group, LLC HALE, GLORIA M 3732 Other Non-Final OA 3d overdue Pending Jul 07, 2025
19234634 LANE CHANGE DETERMINATION FOR VEHICLE ON SHOULDER Embark Trucks Inc. DAGER, JONATHAN M §103 Non-Final OA Pending Jun 11, 2025
19180648 ENCRYPTED SUBNETS AND SECURE CONTAINERS Fr0Ntierx Inc. WORJLOH, JALATEE 3697 §103 Final Rejection Pending Apr 16, 2025
19096095 TOOL IDENTIFIER RECOGNITION AND SENSOR CALIBRATION IN A TOOL CONTROL SYSTEM Snap-On Incorporated ELLIS, SUEZU Y 2876 §103 Non-Final OA 33d Pending Mar 31, 2025
19086306 DECLARATIVE DIGITAL TWINS Cirrus360 LLC JEAN GILLES, JUDE §103 Non-Final OA Pending Mar 21, 2025
19078927 SECURITY IN RADIO ACCESS NETWORKS Cirrus360 LLC GELAGAY, SHEWAYE §103 Non-Final OA Pending Mar 13, 2025
18998825 SYSTEM TO STREAM REAL TIME EVENTS FROM A PUBLISHER WEBPAGE TO ENABLE REAL WORLD PURCHASE BASED ATTRIBUTION Catalina Marketing Corporation DETWEILER, JAMES M 3621 §103 Non-Final OA Pending Jan 27, 2025
18948169 ELECTRICAL VEHICLE INTERNAL GENERATOR Af/Gs Ev In-Gen Patent Jv ORTIZ, ELIM 2836 §103 Non-Final OA Pending Nov 14, 2024
18846253 MERGING TEXT BLOCKS Myscript VU, KIEU D §103 Non-Final OA Pending Sep 12, 2024
18775221 API CONNECTORS AppDirect, Inc. PASHA, ATHAR N 2657 §103 Non-Final OA 57d Pending Jul 17, 2024
18751839 THREE-DIMENSIONAL LATTICE STRUCTURES FOR IMPLANTS Nanohive Medical LLC PRONE, CHRISTOPHER D 3774 §103 Non-Final OA 56d Pending Jun 24, 2024
18658854 SENSOR-INTEGRATED MEDICAMENT DEVICE FOR DATA TRANSFER INTO A VIRTUAL ENVIRONMENT ResMed LETT, THOMAS J 2611 §103 Final Rejection AI Ready May 08, 2024
18655651 SYSTEMS AND METHODS FOR GOAL-DRIVEN CONTEXTUAL OMNICHANNEL OPTIMIZATION USING WELL-ROUNDED ARTIFICIAL INTELLIGENCE Pharmaforceiq, Inc. TC 3600, DOCKET 3600 §103 Final Rejection 22d Pending May 06, 2024
18653171 ARTIFICIAL-INTELLIGENCE-BASED EXECUTION ON BLOCKCHAINS Ava Labs, Inc. RAMIREZ BRAVO, BEATRIZ A 2146 §103 Final Rejection Pending May 02, 2024
18705460 HOMOGENEOUS IMMUNOASSAY METHOD Belgian Volition Srl SVEIVEN, MICHAEL CAMERON §103 Non-Final OA Pending Apr 26, 2024
18644614 EMISSION BASED ENERGY USAGE MANAGEMENT FOR ELECTRICAL POWER SYSTEMS Voltus, Inc. WHITAKER, ANDREW B 3629 §103 Non-Final OA 44d overdue Pending Apr 24, 2024
18638371 FUSED TRIAZOLO-PYRIMIDINE COMPOUNDS HAVING USEFUL PHARMACEUTICAL APPLICATION Piksci Inc. HOWELL, THEODORE R 1628 DP Non-Final OA Pending Apr 17, 2024
18695464 TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF Vellera Therapeutics, Inc. LOCKARD, JON MCCLELLAND 1647 Other Non-Final OA 39d Pending Mar 26, 2024
18594747 IMPLANT WITH INDEPENDENT ENDPLATES Nanohive Medical LLC PRONE, CHRISTOPHER D 3774 §103 Non-Final OA Pending Mar 04, 2024
18027524 TEMPERATURE-CONTROLLED FLUIDIC REACTIONS SYSTEM Catalog Technologies, Inc. NGUYEN, HENRY H §103 Non-Final OA Pending Feb 12, 2024
18431910 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER Impetis Biosciences Ltd. OTTON, ALICIA L 1699 §103 Final Rejection Pending Feb 02, 2024
18291393 ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN Seaspire, Inc. VIGIL, TORIANA NICHOLE 1612 Other Non-Final OA 67d overdue Pending Jan 23, 2024
18571992 SUBSTRATES MODIFIED WITH PEPTOID-LOADED MICROGELS FOR RESISTANCE TO BACTERIAL COLONIZATION Maxwell Biosciences, Inc. SCOTLAND, REBECCA LYNN 1615 §112 Final Rejection 55d Pending Dec 19, 2023
18533500 METHOD AND SYSTEM FOR PROVIDING AN ON-LINE CONFERENCE INCLUDING A MEDICAL IMAGE Medical Isight (Uk) Ltd. MOHAMMED, ASSAD 2691 §103 Final Rejection 5d Pending Dec 08, 2023
18568228 STANDARDISATION OF NUCLEOSOME ASSAYS USING BIOLOGICALLY DERIVED CALIBRANTS Belgian Volition Srl SINES, BRIAN J §102 Non-Final OA Pending Dec 07, 2023
18568209 MACHINE LEARNING SYSTEM AND METHOD TO DETERMINE STEP UP AND STEP DOWN OF TREATMENTS ResMed EVANS, ASHLEY ELIZABETH 3687 §103 Non-Final OA 97d overdue AI Ready Dec 07, 2023
18552649 BICYCLIC HETEROCYCLIC FGFR4 INHIBITOR, PHARMACEUTICAL COMPOSITION AND PREPARATION COMPRISING SAME, AND APPLICATION THEREOF Apeloa Pharmaceutical Co., Ltd. TOWNSLEY, SARA ELIZABETH 1629 §112 Non-Final OA Pending Sep 26, 2023
18552094 SYSTEM TO SELECT IN-STORE OR E-COMMERCE CHANNELS FOR OPTIMIZED DELIVERY OF CREATIVE MEDIA TO CONSUMERS Catalina Marketing Corporation POUNCIL, DARNELL A 3622 §101 Non-Final OA 16d overdue Pending Sep 22, 2023
18455378 ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING SLEEP DISORDERS Curio Ip, LLC CHANDRAKUMAR, NIZAL S 1625 §112 Non-Final OA 92d overdue Pending Aug 24, 2023
18278350 MODIFYING DIGITAL CONTENT INCLUDING TYPED AND HANDWRITTEN TEXT Myscript MCCOY, AIDAN WILLIAM 2611 §103 Non-Final OA 29d overdue Pending Aug 22, 2023
18260011 TRANSCRIPTION FACTOR BINDING SITE ANALYSIS OF NUCLEOSOME DEPLETED CIRCULATING CELL FREE CHROMATIN FRAGMENTS Belgian Volition Srl (Be/Be) SCHLOOP, ALLISON ELIZABETH 1682 §103 Non-Final OA Pending Jun 29, 2023
18260018 CIRCULATING TRANSCRIPTION FACTOR ANALYSIS Belgian Volition Srl (Be/Be) NGUYEN, NAM P 1678 DP Non-Final OA Pending Jun 29, 2023
18256191 DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS Belgian Volition Srl (Be/Be) AEDER, SEAN E 1642 §101 Non-Final OA 9d Pending Jun 06, 2023
18252524 METHODS FOR THE ACCURATE DETECTION OF MUTATIONS IN SINGLE MOLECULES OF DNA Genome Research Limited GRAY, JESSICA 1682 §103 Final Rejection Pending May 10, 2023
18305567 SYSTEM TO ENABLE SPONSORED AD MONETIZATION AND DYNAMIC CONTENT INSERTION AT RUNTIME Catalina Marketing Corporation DETWEILER, JAMES M 3621 §103 Final Rejection Pending Apr 24, 2023
18032070 OPTIMIZING REAL-TIME BIDDING USING CONVERSION TRACKING TO PROVIDE DYNAMIC ADVERTISEMENT PAYLOADS Catalina Marketing Corporation SPAR, ILANA L 3622 §103 Final Rejection 16d overdue Pending Apr 14, 2023
18031916 PHOTOPROTECTIVE COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN AS AN ANTIOXIDANT AND UV-FILTER STABILIZER Seaspire, Inc. BABSON, NICOLE PLOURDE 1619 §103 Final Rejection 26d Pending Apr 14, 2023
18249030 NOVEL TRYPANOSOMAL VACCINE Genome Research Limited OGUNBIYI, OLUWATOSIN A 1645 §112 Final Rejection 30d overdue Pending Apr 13, 2023
18185840 Intelligent Prediction of An Expected Value of User Conversion Airbnb, Inc. PADUA, NICO LAUREN 3626 §103 Final Rejection 46d overdue Pending Mar 17, 2023
18005317 UNIVERSAL SENSOR ALLOWING CONFIGURATION OF INPUTS FOR GATHERING PATIENT FEEDBACK Reciprocal Labs Corporation MUNION, JAMES E 1685 §103 Non-Final OA Pending Jan 12, 2023
18014120 GENERATING AND HANDLING OPTIMIZED CONSUMER SEGMENTS Catalina Marketing Corporation MEINECKE DIAZ, SUSANNA M 3625 §103 Final Rejection 21d Pending Dec 30, 2022
18091902 SYSTEMS, APPARATUS, AND METHODS FOR DETECTING PATHOGENS Innotech Precision Medicine, Inc. HANDY, DWAYNE K 1798 §102 Non-Final OA 146d overdue Pending Dec 30, 2022
18061176 TOKEN-LESS AND KEY-VALUE MAPPING VIRTUAL MACHINES Ava Labs, Inc. TRAINOR, DANIEL BRENNAN 2198 §103 Non-Final OA Pending Dec 02, 2022
17997500 SYSTEM AND METHOD TO IDENTIFY SUITABLE PATIENT SUBGROUPS FOR BIOLOGICS Reciprocal Labs Corporation KANAAN, LIZA TONY 3683 §101 Final Rejection 81d overdue Pending Oct 28, 2022
17929824 TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF Vellera Therapeutics, Inc. LOCKARD, JON MCCLELLAND 1647 §112 Non-Final OA Pending Sep 06, 2022
17929874 TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION Vellera Therapeutics Inc. BRISTOL, LYNN ANNE 1643 §112 Non-Final OA 43d overdue Pending Sep 06, 2022
17895953 TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS Belgian Volition Srl (Be/Be) DUNN, MCKENZIE A 1678 §101 Non-Final OA Pending Aug 25, 2022
17781652 USE OF CELL FREE NUCLEOSOMES AS BIOMARKERS Belgian Volition Srl AEDER, SEAN E 1642 §101 Final Rejection 25d overdue Pending Jun 01, 2022
17826636 VACUUM ASSEMBLIES AND METHODS Rexair LLC ZAWORSKI, JONATHAN R 3723 §103 Final Rejection 4d overdue Pending May 27, 2022
17750787 NATURAL LANGUAGE ANALYSIS OF USER SENTIMENT BASED ON DATA OBTAINED DURING USER WORKFLOW Airbnb, Inc. ARMSTRONG, ANGELA A 2659 §101 Non-Final OA 14d Pending May 23, 2022
17731509 AUTO-GENERATION OF ONLINE LISTING INFORMATION Airbnb, Inc. SITTNER, MICHAEL J 3621 §103 Final Rejection 33d Pending Apr 28, 2022
17658798 SYSTEMS AND METHODS FOR ANALYZING USER INTERACTION DATA USING MACHINE LEARNING TO ORGANIZE SEARCH RESULTS Airbnb, Inc. CLARE, MARK C 3628 §101 Final Rejection Pending Apr 11, 2022
17608076 METHOD FOR THE DETECTION OF PROSTATE CANCER Belgian Volition Sprl VOLKOV, ALEXANDER ALEXANDROVIC 1677 §103 Non-Final OA 73d overdue Pending Nov 01, 2021
17458174 SYSTEM AND APPARATUS FOR POINT-OF-CARE DIAGNOSTICS Quidel Corporation GERIDO, DWAN A 1797 §101 Final Rejection 66d overdue Pending Aug 26, 2021
17310807 METHODS OF USING MICROFLUIDIC POSITIONAL ENCODING DEVICES Elegen Corporation PARISI, JESSICA DANIELLE 1684 Other Non-Final OA 19d overdue Pending Aug 25, 2021
17127810 MONOCLONAL ANTIBODY FUSIONS Quidel Corporation DUTT, ADITI 1675 §103 Final Rejection 18d overdue Pending Dec 18, 2020
16976420 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS Delpor, Inc. VANHORN, ABIGAIL LOUISE 1636 Other Non-Final OA 180d overdue Pending Aug 27, 2020
16914148 PERSONAL INFORMATION VAULT AppDirect, Inc. POPHAM, JEFFREY D 2432 §103 Non-Final OA 40d Pending Jun 26, 2020

Managing McDermott Will & Emery, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month